Eupraxia Pharmaceuticals Files 6-K
Ticker: EPRX · Form: 6-K · Filed: Jul 8, 2025 · CIK: 1581178
Sentiment: neutral
Topics: reporting, foreign-private-issuer, administrative
Related Tickers: EPRX
TL;DR
Eupraxia Pharma (EPRX) filed a 6-K on 7/8/25, confirming they'll use Form 40-F for annual reports.
AI Summary
Eupraxia Pharmaceuticals Inc. filed a Form 6-K on July 8, 2025, reporting as a foreign private issuer. The company is incorporated in Canada and its fiscal year ends on December 31. The filing indicates that Eupraxia Pharmaceuticals Inc. will file its annual reports under cover of Form 40-F.
Why It Matters
This filing provides routine disclosure for foreign private issuers, informing the SEC and investors about the company's reporting status and administrative details.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- EUPRAXIA PHARMACEUTICALS INC. (company) — Registrant
- 001-41923 (company) — SEC File Number
- 201-2067 Cadboro Bay Road Victoria, British Columbia, Canada V8R 5G4 (company) — Principal Executive Office Address
- July 2025 (date) — Reporting Period
- July 8, 2025 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the issuer makes or is required to make public in its home country, files or is required to file with any stock exchange on which its securities are traded, or distributes or is required to distribute to its security holders.
Which form will Eupraxia Pharmaceuticals Inc. use for its annual reports?
Eupraxia Pharmaceuticals Inc. will file its annual reports under cover of Form 40-F.
What is the principal executive office address of Eupraxia Pharmaceuticals Inc.?
The principal executive office address is 201-2067 Cadboro Bay Road, Victoria, British Columbia, Canada V8R 5G4.
What is the Commission File Number for Eupraxia Pharmaceuticals Inc.?
The Commission File Number is 001-41923.
For what month is this Form 6-K report being filed?
This Form 6-K report is being filed for the month of July 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 8, 2025 regarding EUPRAXIA PHARMACEUTICALS INC. (EPRX).